Protection against experimental toxoplasmosis by adoptive immunotherapy

Area of Science:

• Immunology
• Parasitology
• Infectious Diseases

Background:

• Toxoplasmosis, caused by *Toxoplasma gondii*, is a significant global health concern.
• Understanding the immune mechanisms of host resistance is crucial for developing effective treatments and vaccines.

Purpose of the Study:

• To investigate the roles of humoral and cell-mediated immunity in protection against *Toxoplasma gondii* infection.
• To determine the contribution of specific immune components in a guinea pig model.

Main Methods:

• Utilized a syngeneic passive transfer system in experimentally infected guinea pigs.
• Transferred serum or spleen and lymph node cells from *Toxoplasma*-immune guinea pigs to naive recipients.
• Assessed parasite dissemination and disease development in recipient animals.
• Investigated the role of T cells by using enriched T cell populations and anti-T cell antibody treatment.

Main Results:

• Immune serum and immune cells (spleen and lymph node) conferred partial protection against symptomatic toxoplasmosis.
• Reduced parasite dissemination to various organs was observed in recipients of immune serum or cells.
• Cell suspensions enriched for immune T cells also provided partial protection.
• Depletion of T cells from immune cell transfers abolished the protective effect.

Conclusions:

• Both humoral immunity (via serum factors) and cell-mediated immunity (specifically T cells) are critical effector mechanisms in host resistance to *Toxoplasma gondii*.
• These findings provide direct evidence for the dual role of adaptive immunity in controlling toxoplasmosis.
• The study highlights the importance of T cell-mediated responses in preventing parasite dissemination.